NCT00108238View on ClinicalTrials.gov

Estrogen Alternatives Study

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 2003

Study Completion Date

December 31, 2006

Conditions

Healthy

Interventions

DRUG

Estradiol followed by progesterone

DRUG

Raloxifene

Trial Locations (1)

48105

VA Ann Arbor Healthcare System, Ann Arbor

All Listed Sponsors

lead

US Department of Veterans Affairs

FED

NCT00108238 - Estrogen Alternatives Study | Biotech Hunter | Biotech Hunter